Australia's largest stock trading and investment forum Australia's #1 stock forum

AN1

Click for more information

0.00%

0.8¢ anagenics limited

The freezers might have been moved down the corridor Taurean7 to...

First 289 Last

Share
Profile

Follow
poorinvestor

385 Posts.

728

15/05/21

08:37

Post #: 53193601
Share

Originally posted by Taurean7: ↑

I doubt that any assets have been transferred physically as a result of the sale. In the near term at least I expect Lyramid’s office will remain down the corridor from Cellmid’s, staff will remain in their same chairs, and antibodies still will be stored in the same freezers. The difference is that now funded by outsiders those antibody vials can be taken out and put to use wherever appropriate.

I assume Lyramid remains an Australian registered company for tax purposes, with any local R&D expenses qualifying for ATO refunding. With most of the income support paid to its owner likely to derive from different international sources, and costs being met by international collaborators, there might well be an advantage in its owner being registered in a secrecy jurisdiction.

Good advice about putting the feet up, Ozjin. Enough from me. Other work to do unfortunately.

Expand

The freezers might have been moved down the corridor Taurean7 to make things easier for the accountants.

poorinvestor

CDY Price at posting: 6.3¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce scores $6.75M R&D rebate

BIO

Biome reaches intellectual property milestone in strain development program

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

RSG

HotCopper reacts as Resolute Mining told to pay US$160M if it wants its CEO back

HAS

Yangibana 33% complete says Hastings, as it provides clarification on funding

First 289 Last

Add AN1 (ASX) to my watchlist